Study: NCT05152420

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VMX-C001
Description: VMX-C001 is human factor X engineered to be insensitive to factor Xa DOACs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: VMX-C001 matched placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: FXa Inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: FXa Inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: FXa Inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: FXa Inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: FXa Inhibitor